Muscle Loss in Colorectal Cancer Tied to Poor Outcomes
Colorectal cancer patients with a muscle loss phenotype face significantly worse postoperative outcomes.
Newsletter
Every new paper in this field, in your inbox.
Colorectal cancer patients with a muscle loss phenotype face significantly worse postoperative outcomes.
Current literature shows significant variability in the definitions of colon cancer segments, affecting treatment and outcomes.
Routine hematological biomarkers enhance diagnosis and surgical decision-making in bowel obstruction.
A composite endpoint approach can help assess outcomes in simultaneous resections for colon cancer with synchronous liver metastases, improving clinical trial efficiency.
The TROPIS procedure shows promise for treating high complex anal fistulas with strong outcomes.
Multimodal prehabilitation significantly enhances outcomes for colorectal cancer patients undergoing surgery by lowering complications and improving recovery.
Minimally invasive surgery for small bowel neuroendocrine tumors shows significant benefits over open resection.
Cold snare biopsy (CSB) significantly boosts diagnostic accuracy for suspected colorectal cancer compared to cold forceps biopsy (CFB), without increasing complication rates.
Surgeons need to adapt to evolving diagnostic and treatment protocols for rectal cancer to enhance patient outcomes.
Postoperative infections in gastric and colorectal cancer surgeries significantly increase costs and hospital stays, demanding urgent attention.